CBRE Group
CBRE
$147.45
-2.45%
CBRE Group is the world's largest commercial real estate services and investment firm, offering a comprehensive suite of services including brokerage, leasing, property and facilities management, valuation, mortgage services, and investment management to occupiers and investors across all major property types. As the undisputed market leader in its industry, CBRE operates in over 100 countries with more than 155,000 employees, leveraging its scale and global platform to serve clients across more than 250 markets. The current investor narrative centers on the company's ability to navigate a challenging commercial real estate environment characterized by high interest rates and shifting office demand, while simultaneously capitalizing on growth opportunities in data centers, logistics, and other high-demand property sectors. Recent market volatility, including a sharp selloff in February 2026, has raised questions about near-term earnings momentum, but the company's diversified business model and strategic investments in technology and high-growth segments continue to attract analyst attention.…
CBRE
CBRE Group
$147.45
Investment Opinion: Should I buy CBRE Today?
Based on the analysis, CBRE is rated a Buy. The thesis is that the company's strong revenue growth and forward valuation offer an attractive risk/reward, with analysts seeing 22.9% upside to the average target of $180.42. The consensus recommendation is Buy, supported by recent upgrades and positive ratings from major institutions.
Sign up to view all
CBRE 12-Month Price Forecast
The AI assessment is bullish on CBRE, driven by strong revenue acceleration and a compelling forward valuation. The market is pricing in a significant earnings recovery, and if the company delivers, the stock has substantial upside. However, the medium confidence reflects the cyclical risks and the high trailing PE. Key factors to watch include revenue growth sustainability and margin expansion. If revenue growth decelerates or margins fail to improve, the stance would be downgraded to neutral. Conversely, if the company beats earnings and raises guidance, the stance could be upgraded to high confidence.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on CBRE Group's 12-month outlook, with a consensus price target around $181.25 and implied upside of +22.9% versus the current price.
Average Target
$181.25
0 analysts
Implied Upside
+22.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$144 - $200
Analyst target range
The target price range spans from a low of $144.00 to a high of $200.00, with the low target slightly below the current price, implying a potential downside of 1.9%, while the high target suggests an upside of 36.2%. The wide spread of $56 between the low and high targets reflects uncertainty about the pace of recovery in commercial real estate markets and the company's ability to sustain its growth trajectory. Recent institutional ratings show a pattern of reaffirmations and upgrades, with UBS upgrading from Neutral to Buy in February 2026, and Evercore ISI, Barclays, and Keefe, Bruyette & Woods all maintaining positive ratings (Outperform or Overweight) throughout 2026, indicating that analysts are becoming more confident in the stock's prospects.
Bulls vs Bears: CBRE Investment Factors
CBRE presents a mixed picture: strong revenue growth and a compelling forward valuation are offset by a high trailing PE and sector headwinds. The bull case is supported by accelerating revenue, analyst upgrades, and a diversified model, while the bear case highlights underperformance, leverage, and interest rate risks. Currently, the bull case has stronger evidence given the 18.2% revenue growth and the 22.9% upside to analyst targets. The central tension is whether the expected earnings recovery will materialize as the forward PE implies, or if persistent high rates and sector weakness will delay it. If earnings recover as expected, the stock is undervalued; if not, the high trailing PE could lead to further de-rating.
Bullish
- Strong Revenue Acceleration: Q1 2026 revenue grew 18.2% YoY to $10.527B, up from $8.91B in Q1 2025, marking a significant acceleration from prior quarters. This growth is broad-based, with Advisory Services and Project Management leading, indicating strong demand across the business.
- Attractive Forward Valuation: The forward PE of 16.21x is a 60.9% discount to the trailing PE of 41.44x, implying the market expects substantial earnings recovery. With a PEG of 1.82x, the stock is reasonably priced relative to its expected growth, offering value for long-term investors.
- Analyst Confidence and Upgrades: Analysts have a consensus Buy rating with an average target of $180.42, implying 22.9% upside from the current price of $146.81. Recent upgrades from UBS and reaffirmations from Evercore ISI, Barclays, and KBW signal growing institutional confidence in the stock's recovery.
- Diversified Business Model: CBRE operates across brokerage, leasing, property management, and investment management, with revenue from multiple segments. This diversification reduces reliance on any single market, providing resilience in a challenging commercial real estate environment.
Bearish
- High Trailing PE Indicates Cyclical Trough: The trailing PE of 41.44x is elevated, reflecting depressed earnings over the past year. If the expected earnings recovery does not materialize, the stock could face de-rating, as the market may not be willing to pay such a premium for cyclical earnings.
- Underperformance vs. S&P 500: CBRE is down 5.7% over the past year, while the S&P 500 is up 18.2%, a relative underperformance of 23.9%. This suggests persistent negative sentiment and potential headwinds specific to the commercial real estate sector.
- High Debt-to-Equity Ratio: The debt-to-equity ratio of 1.13x indicates a leveraged balance sheet. In a rising interest rate environment, this increases interest expense and financial risk, potentially constraining growth and profitability.
- Sector Headwinds from High Interest Rates: High interest rates continue to pressure commercial real estate valuations and transaction volumes. CBRE's brokerage and leasing businesses are directly impacted, and a prolonged high-rate environment could delay the expected recovery.
CBRE Technical Analysis
CBRE's price trend over the past year has been characterized by a significant decline, with the stock down 5.7% over the past year, underperforming the S&P 500's 18.2% gain. The current price of $146.81 sits at 71.4% of its 52-week range (between $121.69 low and $174.27 high), indicating the stock is trading in the lower-middle portion of its range, reflecting a market that has been cautious on the commercial real estate sector. This positioning suggests the stock is neither at extreme oversold levels nor showing strong momentum, but rather consolidating after a period of weakness that saw the price drop from its February 2026 high of $174.27 to a May 2026 low of $121.69, a decline of over 30% from peak to trough.
Beta
1.19
1.19x market volatility
Max Drawdown
-27.4%
Largest decline past year
52-Week Range
$122-$174
Price range past year
Annual Return
-5.4%
Cumulative gain past year
| Period | CBRE Return | S&P 500 |
|---|---|---|
| 1m | +2.6% | +2.8% |
| 3m | +0.8% | +4.2% |
| 6m | -13.1% | +11.3% |
| 1y | -5.4% | +21.5% |
| ytd | -8.0% | +12.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CBRE Fundamental Analysis
CBRE's revenue trajectory has been robust, with the most recent quarter (Q1 2026) showing revenue of $10.527 billion, a 18.2% year-over-year increase from $8.91 billion in Q1 2025. This growth represents a significant acceleration from the prior year's quarters, where revenue grew from $8.391 billion in Q2 2024 to $10.404 billion in Q4 2024, and then to $10.258 billion in Q3 2025, indicating a strong upward trend. The growth is driven by strength across all segments, particularly Advisory Services ($2.024 billion) and Project Management ($1.838 billion), which together account for the majority of revenue, while Real Estate Investments contributed $199 million, showing the diversified nature of the business.
Quarterly Revenue
$10.5B
2026-03
Revenue YoY Growth
+18.1%
YoY Comparison
Gross Margin
17.6%
Latest Quarter
Free Cash Flow
$897000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CBRE Overvalued?
Given that CBRE has positive net income, the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE is 41.44x, while the forward PE is 16.21x, indicating that the market expects significant earnings growth in the coming year, with the forward PE implying a 60.9% discount to the trailing multiple. This gap suggests that the market is pricing in a substantial recovery in earnings, likely driven by the company's revenue growth and margin expansion initiatives. The PEG ratio of 1.82x further supports the view that the stock is reasonably valued relative to its expected growth, though the high trailing PE reflects the cyclical trough in earnings experienced over the past year.
PE
41.4x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 12x~74x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
21.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks stem from CBRE's leverage and cash flow. With a debt-to-equity ratio of 1.13x, the company has significant debt obligations, and rising interest rates increase interest expense, which was $59M in Q1 2026. The operating margin is thin at 3.2%, leaving little room for error, and the net margin of 2.9% is low, indicating that even small revenue declines could disproportionately impact earnings. Additionally, the company's reliance on cyclical real estate markets means that a downturn could lead to revenue concentration risk, as seen in the 30% drop in stock price from peak to trough in early 2026.
FAQ
The key risks are: 1) Financial risk from high debt-to-equity of 1.13x, which could strain cash flow if interest rates rise; 2) Market risk from cyclicality in commercial real estate, as seen in the 30% drop from peak to trough in early 2026; 3) Competitive risk from rivals like JLL and Cushman & Wakefield; 4) Macro risk from high interest rates dampening transaction volumes. The most severe risk is a prolonged downturn in real estate, which could lead to earnings misses and a de-rating of the stock.
The 12-month forecast is bullish, with a base case target of $160-$180 (50% probability), a bull case of $180-$200 (30% probability), and a bear case of $120-$140 (20% probability). The most likely scenario is the base case, where the stock reaches the analyst average target of $180.42, implying 22.9% upside. This assumes steady revenue growth and margin improvement. The bull case would require a faster recovery in real estate markets, while the bear case would involve persistent high rates and weak demand.
CBRE appears undervalued based on forward metrics, with a forward PE of 16.21x versus a trailing PE of 41.44x, implying the market expects a significant earnings recovery. The PEG ratio of 1.82x suggests the stock is reasonably priced relative to its growth. Compared to peers, the PS ratio of 1.18x is moderate. The market is pricing in a recovery, and if that occurs, the stock is undervalued; if not, the high trailing PE could indicate overvaluation. Overall, the valuation is attractive for a growth-oriented investor.
CBRE is a good buy for investors with a medium-to-long-term horizon who are comfortable with cyclical volatility. The stock offers a 22.9% upside to the average analyst target of $180.42, and the forward PE of 16.21x is attractive relative to the expected earnings recovery. However, the high trailing PE of 41.44x and the stock's underperformance versus the S&P 500 over the past year highlight the risks. If you believe the commercial real estate market will recover, CBRE is a compelling buy; otherwise, it may be prudent to wait for more clarity.
CBRE is more suitable for long-term investment due to its cyclical nature and the expected multi-year recovery in commercial real estate. The stock has a beta of 1.205, indicating higher volatility, which may not suit short-term traders. The company pays no dividend, so returns depend on capital appreciation. Given the forward PE discount and analyst targets, a holding period of at least 2-3 years is recommended to allow the earnings recovery to play out. Short-term traders may find opportunities in the stock's volatility, but the fundamental thesis is best captured over a longer horizon.